The Potential Clinical and Economic Value of a Human Papillomavirus Primary Screening Test That Additionally Identifies Genotypes 31, 45, 51, and 52 Individually-Reference-Cited by-同舟云学术

The Potential Clinical and Economic Value of a Human Papillomavirus Primary Screening Test That Additionally Identifies Genotypes 31, 45, 51, and 52 Individually

Published:2020-11-05 Issue:5 Volume:48 Page:370-380
ISSN:1537-4521
Container-title:Sexually Transmitted Diseases
language:en
Short-container-title:Sexual Trans Dis

Author:

Asti Lindsey,Hopley Colin,Avelis Cameron,Bartsch Sarah M.,Mueller Leslie E.,Domino Molly,Cox Sarah N.,Andrews Jeffrey C.,Randall Samuel L.,Stokes-Cawley Owen J.,Asjes Caitlin,Lee Bruce Y.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Microbiology (medical),Public Health, Environmental and Occupational Health,Dermatology

Reference28 articles.

1. Comparison of seven tests for high-grade cervical intraepithelial neoplasia in women with abnormal smears: The Predictors 2 study;J Clin Microbiol,2012

2. Comparing the performance of six human papillomavirus tests in a screening population;Br J Cancer,2013

3. Use of primary high-risk human papillomavirus testing for cervical cancer screening: Interim clinical guidance;Gynecol Oncol,2015

4. The Onclarity Human Papillomavirus Trial: Design, methods, and baseline results;Gynecol Oncol,2018

5. Individual detection of 14 high risk human papilloma virus genotypes by the PapType test for the prediction of high grade cervical lesions;J Clin Virol,2014

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost‐effectiveness of primary human papillomavirus triage approaches among vaccinated women in Norway: A model‐based analysis;International Journal of Cancer;2023-12-13

2. Economic evaluations of predictive genetic testing: A scoping review;PLOS ONE;2023-08-02

3. Cost-Effectiveness Analysis of HPV Extended versus Partial Genotyping for Cervical Cancer Screening in Singapore;Cancers;2023-03-16

4. Health care provider's experience and perspective of cervical cancer screening in Singapore: A qualitative study;Frontiers in Public Health;2022-07-26

5. Is It Time to Genotype Beyond HPV16 and HPV18 for Cervical Cancer Screening?;International Journal of Public Health;2022-05-12